Jump to Main Contents
ncc en

Home > Information


Oct. 12, 2018
Cancer Registration Training at Cambodia and Viet Nam
Oct. 1, 2018
National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment
Sep. 18, 2018
Visit to Norman E. Sharpless MD and his delegation at the National Cancer Institute
Sep. 15, 2018
Projected Cancer Statistics, 2018
Aug. 22, 2018
National Cancer Center Japan - IARC Seminar 4
Aug. 8, 2018
Dr Masaaki Ito appointed Honorary Professor at China-Japan Friendship Hospital
Aug. 2, 2018
Organization Chart Updated
Jun. 27, 2018
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
Jun. 1, 2018
NCC Establishes Center for Cancer Genomics and Advanced
Therapeutics (C-CAT) to Aggregate and Manage Information on
Cancer Genomic Medicine and Promote Its Use
May 28, 2018
New Agreement with National Cancer Hospital, Vietnam
May 7, 2018
National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
Apr. 23, 2018
National Cancer Center – IARC Seminar 3
Apr. 3, 2018
National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system
Apr. 3, 2018
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine
Mar. 30, 2018
NCC joins China and Korea at the first 3 national cancer centers’ workshop
Mar. 19, 2018
Cancer Registration Seminar in Indonesia
Mar. 13, 2018
SCRUM-Japan GI-SCREEN Aims for Realizing of Cancer Precision Medicine Utilizing Liquid Biopsy by Analyzing Comprehensive Cancer Genome Alterations in Blood
Mar. 9, 2018
WHO Classification of Tumours Series appoints Dr Ochiai to Editorial Board
Feb. 14, 2018
A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects
Feb. 5, 2018
Maestro Chung Visit
Jan. 23, 2018
Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style
Dec. 22, 2017
T. Matsuda takes office of International Association of Cancer Registries President
Dec. 18, 2017
Cancer Statistics in Japan; Table download
Dec. 14, 2017
National Cancer Center - IARC Seminar 2
Dec. 5, 2017
NCC signs comprehensive MoU with WHO/IARC
Nov. 27, 2017
Asian Early Phase Oncology Drug Development Consortium Formed
Nov. 21, 2017
New Agreement with National Cancer Center, Indonesia
Nov. 14, 2017
Lithuanian Health Minister Visit
Oct. 30, 2017
Cancer Statistics in Japan; Table download
Oct. 27, 2017
Collaborative Research on Fully-personalized Cancer Neoantigen Vaccine
Oct. 27, 2017
Projected Cancer Statistics, 2017
Oct. 26, 2017
National Cancer Center - IARC Seminar 1
Oct. 16, 2017
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
Aug. 3, 2017
Japan-Singapore lead international research in discovering potential targeted treatments for biliary tract cancer
Aug. 1, 2017
On-Table Adaptive Radiation Therapy
Jul. 31, 2017
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia
Jul. 21, 2017
Cancer Registration Seminar in Myanmar
Jul. 11, 2017
Cancer Statistics in Japan; Table download
Jun. 26, 2017
A novel biomarker for development of a new screening technique for early-stage pancreatic cancer and precancerous conditions associated with risk of pancreatic malignancy - experimental screening in Kagoshima Prefecture
Jun. 16, 2017
National Cancer Center hosts Iranian Delegation
May 30, 2017
WHO/International Agency for Research on Cancer establishes National Cancer Center as Global Initiative for Cancer Registry Development Collaborating Centre
Apr. 27, 2017
Elucidation of the mechanism of MLL-rearranged leukemia Use of two molecularly targeted drugs as novel therapy
Mar. 1, 2017
Commencement of Phase 1 Trial for the Mutant IDH1 Inhibitor (DS-1001)Targeting Malignant Brain Tumors
Feb. 28, 2017
Malignant extracellular vesicles derived from ovarian cancer cells facilitate peritoneal dissemination, and the vesicles can be promising targets for improving patient outcomes.
Feb. 21, 2017
Signing MOU with the National Cancer Research Institute (UK)